Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
No treatment given
Locations
10
Australia
Novo Nordisk Investigational Site
Sydney, Australia
Novo Nordisk Investigational Site
Bogotá, Colombia
Novo Nordisk Investigational Site
Rome, Italy
Novo Nordisk Investigational Site
Mexico City, Mexico
Novo Nordisk Investigational Site
Riyadh, Saudi Arabia
Novo Nordisk Investigational Site
Seoul, South Korea
Start Date
August 23, 2021
Primary Completion Date
December 13, 2021
Completion Date
December 13, 2021
Last Updated
February 2, 2022
NCT07351045
NCT07543666
NCT07037459
NCT07508241
NCT07244458
NCT07311850
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions